Correlation Between Lyra Therapeutics and Revolution Medicines
Can any of the company-specific risk be diversified away by investing in both Lyra Therapeutics and Revolution Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyra Therapeutics and Revolution Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lyra Therapeutics and Revolution Medicines, you can compare the effects of market volatilities on Lyra Therapeutics and Revolution Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyra Therapeutics with a short position of Revolution Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyra Therapeutics and Revolution Medicines.
Diversification Opportunities for Lyra Therapeutics and Revolution Medicines
-0.51 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Lyra and Revolution is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Lyra Therapeutics and Revolution Medicines in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revolution Medicines and Lyra Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyra Therapeutics are associated (or correlated) with Revolution Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revolution Medicines has no effect on the direction of Lyra Therapeutics i.e., Lyra Therapeutics and Revolution Medicines go up and down completely randomly.
Pair Corralation between Lyra Therapeutics and Revolution Medicines
Given the investment horizon of 90 days Lyra Therapeutics is expected to under-perform the Revolution Medicines. In addition to that, Lyra Therapeutics is 3.12 times more volatile than Revolution Medicines. It trades about -0.18 of its total potential returns per unit of risk. Revolution Medicines is currently generating about 0.27 per unit of volatility. If you would invest 4,851 in Revolution Medicines on August 24, 2024 and sell it today you would earn a total of 827.00 from holding Revolution Medicines or generate 17.05% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lyra Therapeutics vs. Revolution Medicines
Performance |
| Timeline |
| Lyra Therapeutics |
| Revolution Medicines |
Lyra Therapeutics and Revolution Medicines Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lyra Therapeutics and Revolution Medicines
The main advantage of trading using opposite Lyra Therapeutics and Revolution Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyra Therapeutics position performs unexpectedly, Revolution Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revolution Medicines will offset losses from the drop in Revolution Medicines' long position.| Lyra Therapeutics vs. CytomX Therapeutics | Lyra Therapeutics vs. Assembly Biosciences | Lyra Therapeutics vs. Achilles Therapeutics PLC | Lyra Therapeutics vs. Instil Bio |
| Revolution Medicines vs. Lyra Therapeutics | Revolution Medicines vs. Hookipa Pharma | Revolution Medicines vs. Cingulate Warrants | Revolution Medicines vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| CEOs Directory Screen CEOs from public companies around the world |